Oteo-Iglesias, JesusSaez, DavidBautista, VeronicaFernandez-Romero, SaraHernández-Molina, Juan ManuelPerez-Vazquez, MariaAracil, BelenCampos, Jose2019-11-142019-11-142013-12Antimicrob Agents Chemother. 2013 Dec;57(12):6344-7.0066-4804http://hdl.handle.net/20.500.12105/8588We report the epidemiological impact of carbapenemase-producing Enterobacteriaceae (CPE) in Spain in 2012. Of the 237 carbapenemases detected, 163 were from the OXA-48 group, 60 were from VIM-1, 8 were from KPC-2, 5 were from IMP, and 1 was from NDM-1. Interhospital spread of carbapenemase-producing Klebsiella pneumoniae was due to a limited number of multilocus sequence types (MLST) and carbapenemase types, including ST15-VIM-1, ST11-OXA-48, ST405-OXA-48, ST101-KPC-2, and ST11-VIM-1. The number of CPE cases in Spain has increased sharply in recent years, due mainly to the emergence of OXA-48.engAMhttp://creativecommons.org/licenses/by-nc-sa/4.0/Anti-Bacterial AgentsBacterial ProteinsEnterobacteriaceaeHumansMicrobial Sensitivity TestsMultilocus Sequence TypingSpainbeta-LactamasesAtribución-NoComercial-CompartirIgual 4.0 Internacional2404189857126344-710.1128/AAC.01513-131098-6596Antimicrobial agents and chemotherapyopen access